suicide gene therapy (Austrianova)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namesuicide gene therapy (Austrianova)

Drug Alias Nameretroviral Cyt P450 2B1/cyclophosphamide therapy (Austrianova)

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Retroviral vector

Mechanisms of ActionCytochrome P450 stimulants

TargetsCytochrome P450

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustria

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSg Austria

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSg Austria

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A